Paracentesis is Safe During Acute Encephalopathy
Paracentesis should be performed in patients with acute encephalopathy and ascites, as it is safe and may actually improve outcomes in this high-risk population. The presence of hepatic encephalopathy is not a contraindication to paracentesis and should not delay the procedure 1, 2.
Evidence Supporting Safety in Encephalopathy
The most recent AGA guidelines (2025) explicitly state that therapeutic paracentesis is safe and effective, with fewer complications compared to intensive diuretic therapy, including lower rates of hepatic encephalopathy (HE) 1. In fact, paracentesis reduces the risk of HE compared to aggressive diuretic use.
A large retrospective study of over 75,000 hospitalizations demonstrated that patients with concomitant hepatic encephalopathy present on admission (classified as "high-risk") can safely undergo paracentesis 3. Critically, early paracentesis (within 1 hospital day) in these high-risk patients with encephalopathy was associated with:
- 32% reduction in all-cause inpatient mortality (OR 0.68)
- 16% reduction in SBP-related mortality (OR 0.84)
- 13% reduction in 30-day readmission (OR 0.87) 3
Key Safety Considerations
Coagulopathy is NOT a Contraindication
- Prophylactic transfusions for thrombocytopenia or coagulopathy are not advised 1
- Postparacentesis bleeding is rare even with coagulopathy or thrombocytopenia 1
- Major bleeding complications occur in only 1.6% of procedures overall 4
- Pediatric data confirms safety even with thrombocytopenia, prolonged PT, and encephalopathy 5
Albumin Administration Protocol
When performing paracentesis in encephalopathy patients:
- For volumes >5 L: Administer 20-25% IV albumin at 6-8 g per liter removed 1, 2
- For patients with hypotension, renal insufficiency, or electrolyte abnormalities: Consider albumin even for smaller volumes 1
- Limit single-session removal to <8 L when possible, as risk of postparacentesis circulatory dysfunction increases beyond this threshold 2
Timing is Critical
- Perform paracentesis within 1 hospital day of admission 3, 6
- Paradoxically, high-risk patients with encephalopathy are less likely to receive early paracentesis (52.8% vs 60.5%), representing a quality gap 3
- Delayed paracentesis is associated with worse outcomes 3, 6
Common Pitfalls to Avoid
Delaying paracentesis due to encephalopathy: This is counterproductive—encephalopathy is an indication for diagnostic paracentesis to rule out SBP, and therapeutic paracentesis may improve mental status by reducing abdominal distention and metabolic stress
Withholding procedure due to coagulopathy: The bleeding risk is minimal and does not justify prophylactic plasma or platelet transfusions 1
Omitting albumin replacement: This increases risk of postparacentesis circulatory dysfunction, which can paradoxically worsen encephalopathy, cause renal impairment, and increase mortality 2
Removing >8 L in a single session without appropriate albumin dosing: Consider staged procedures if massive ascites is present 2
Clinical Bottom Line
The presence of acute encephalopathy should prompt earlier rather than delayed paracentesis. The procedure is safe, guideline-recommended, and associated with improved mortality in this exact patient population. Ensure adequate albumin replacement for large-volume procedures and proceed without delay for coagulopathy correction.